To the Editor In a recent Research Letter, Yang et al¹ argue against public reporting of short-term percutaneous coronary interventions (PCI) mortality at the site level for physicians practicing at multiple sites. They state that in New York’s 2014-2016 Percutaneous Coronary Interventions report,² 15 physicians who performed PCI at multiple sites are outliers in one of the sites but only 4 of the 15 are outliers when data from the multiple sites are combined. However, the report itself, which was not cited as a reference by Yang et al,¹ identifies only 6 site-specific outliers among physicians performing at more than 1 site, with all but 2 (one of which had lower-than-expected mortality) also identified when all sites are combined.^2pp35-49

致编辑在最近的一篇研究信函中，Yang 等人¹反对公开报告在多个地点执业的医生在地点级别的短期经皮冠状动脉介入治疗 (PCI) 死亡率。他们指出，在纽约的 2014-2016 年经皮冠状动脉介入治疗报告中，有² 15 名在多个地点进行 PCI 的医生是其中一个地点的异常值，但当合并来自多个地点的数据时，15 名医生中只有 4 名是异常值。然而，该报告本身并未被 Yang 等人引用作为参考，¹仅在超过 1 个地点的医生中确定了 6 个特定地点的异常值，除了 2 个（其中一个的死亡率低于预期） ) 也可以在所有站点合并时进行标识。^2pp35-49